The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial.

[1]  Bradley E. Chipps Daily Versus As-Needed Corticosteroids for Mild Persistent Asthma , 2006, Pediatrics.

[2]  P. Paggiaro,et al.  Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients. , 2006, Chest.

[3]  C. Brightling Sputum induction in asthma: a research technique or a clinical tool? , 2006, Chest.

[4]  J. Cowan,et al.  Exhaled nitric oxide: a predictor of steroid response. , 2005, American journal of respiratory and critical care medicine.

[5]  J. Cowan,et al.  Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. , 2005, The New England journal of medicine.

[6]  E. Israel,et al.  Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. , 2005, The Journal of allergy and clinical immunology.

[7]  G. Heldt,et al.  Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. , 2005, The Journal of allergy and clinical immunology.

[8]  R. Pauwels,et al.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. , 2004, American journal of respiratory and critical care medicine.

[9]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[10]  E. Israel,et al.  Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. , 2001, JAMA.

[11]  E. Juniper,et al.  Measuring asthma control in group studies: do we need airway calibre and rescue beta2-agonist use? , 2001, Respiratory medicine.

[12]  K. J. Macleod,et al.  Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma , 2000, Thorax.

[13]  I. Pavord,et al.  Non-eosinophilic cor ticosteroid unresponsive asthma , 1999, The Lancet.

[14]  S. Szefler,et al.  Time to onset of effect of fluticasone propionate in patients with asthma. , 1999, The Journal of allergy and clinical immunology.

[15]  Lynn Wei,et al.  Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma , 1999, Annals of Internal Medicine.

[16]  W. Busse Inflammation in asthma: the cornerstone of the disease and target of therapy. , 1998, The Journal of allergy and clinical immunology.

[17]  W. Busse,et al.  Efficacy and safety of inhaled corticosteroids. New developments. , 1998, American journal of respiratory and critical care medicine.

[18]  Romain A. Pauwels GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[19]  E. Israel,et al.  Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. , 1996, The New England journal of medicine.

[20]  G. E. Noether,et al.  Sample Size Determination for Some Common Nonparametric Tests , 1987 .

[21]  H. Neijens,et al.  Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. , 1987, The Journal of allergy and clinical immunology.

[22]  Stephen C Lazarus,et al.  Banks CORTICOSTEROIDS FOR PERSISTENT ASTHMA SIGNIFICANT VARIABILITY IN RESPONSE TO INHALED Services , 2022 .